Why the study?
Does the ACS:180 Cardiac Troponin I assay perform as efficiently as other cardiac biomarkers in diagnosing acute myocardial infarction in patients with suspected acute coronary syndromes?
Population
Patients admitted to the coronary care unit with suspected acute coronary syndromes, and a separate group of…
Comparison
ACS:180 Cardiac Troponin I (cTnI) assay vs Other cardiac biomarkers including creatine…
Design
Cohort
Follow-up
12 hours
Authors
Loading...
ACS:180 cTnI performs equivalently to CK-MB and cTnT for AMI diagnosis and UA risk stratification; observational data leaves open need for prospective validation.
Does the ACS:180 Cardiac Troponin I assay perform as efficiently as other cardiac biomarkers in diagnosing acute myocardial infarction in patients with suspected acute coronary syndromes?
The ACS:180 cTnI assay demonstrates equivalent diagnostic efficiency to CK-MB and cTnT for acute myocardial infarction and risk stratification in unstable angina.
Collinson et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: